Peggy Sotiropoulou

Company: Celyad Oncology

Job title: Head of Research & Development

Seminars:

Differentiated Non-Gene Edited Technologies to Generate Off-The-Shelf CAR-T Cells for the Treatment of Hematopoietic and Solid Malignancies 11:35 am

• Leveraging non-gene edited technologies to disrupt TCR signaling to generate allogeneic CAR T cells • Exploiting natural receptor/ligand interactions for CAR T cell therapy of metastatic colorectal cancer • Discussing the first-in-class shRNA-based BCMA-targeting allogeneic CAR T candidate for the treatment of multiple myelomaRead more

day: Day Two